 |
| Acute Ischemic Stroke Diagnosis and Treatment Market |
Acute ischemic stroke refers to a sudden loss of certain brain function
owing to uneven or lack of blood to the brain. Acute ischemic functions are
mainly triggered by atherosclerosis plaques blocking blood vessels, blood clots
locking the blood distribution to or from arteries nourishing the brain, or
narrowing of blood vessels of the brain. Acute ischemic stroke is one of the
major causes of permanent disability in the patients. It is also the third
largest reason of death worldwide.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/acute-ischemic-stroke-diagnosis-and-treatment-market/report-sample
Some of the other factors driving the market include, aging population
mainly in the developed countries of Europe and North America. The development
of the effective medication in the treatment of ischemic stroke is accepted to
hinder the acceptance of expensive surgery in the ischemic stroke diagnosis
market. The development of desmoteplase, a novel next-generation thrombolytic,
is one of the major advancement of in the treatment technology of acute
ischemic stroke. It provides extended therapeutic time compared to most of the
other treatment procedure.
Access Detailed Report Summary@ https://www.psmarketresearch.com/market-analysis/acute-ischemic-stroke-diagnosis-and-treatment-market
According to the American Heart Association, acute ischemic stroke is among
the top three causes of death in the U.S. and Canada, nearly 795,000 patients
suffering from strokes are treated in the 2014. Out of which 85% of patients
were suffering from ischemic strokes.
North America was the largest market of acute ischemic stroke diagnosis and
treatment in 2014. The market dominance of the North America is attributed to
high percentage of patients suffering from strokes, in admiration with the
technical advancement in the treatment procedure acute ischemic stroke in the
region. It is then followed by Europe; the large population of baby boomers in
Europe is one of the factors for a high market share in acute ischemic stroke
diagnosis and treatment market. Country wise, the U.S., Canada are two of the
major markets in North America. Germany, Italy, the U.K, and France are some of
the dominant market in Europe, Japan, China and India are the major market of
Asia Pacific region.
Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=acute-ischemic-stroke-diagnosis-and-treatment-market
Some of the leading players operating in global acute ischemic stroke
diagnosis and treatment market include, Abbott Laboratories, Covidien
plc, Johnson & Johnson (Cordis Corporation), Penumbra, Inc., Philips
Healthcare, GE Healthcare, Hitachi, Ltd., Siemens Healthcare, and Stryker
Corporation (Concentric Medical, Inc.)
No comments:
Post a Comment